Continuing Education Event – Everything You Need to Know About Medications for the Treatment of Opioid Use Disorder – webinar – 1/28/2021
The American Society of Addiction Medicine revised the definition of addiction in 2019 as follows: “Addiction is a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual’s life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences. Prevention efforts and treatment approaches for addiction are generally as successful as those for other chronic diseases.” This training will focus on the disease of opioid use disorder (OUD) and the medications used in combination with behavioral treatment to manage this chronic disease and assist patients in achieving recovery and long-term sobriety.
1. Review & define terminology and abbreviations commonly used in OUD treatment: MAT, MOUD, OAT, opioid agonist, partial opioid agonist, opioid antagonist, opiate vs opioid, detoxification vs maintenance.
2. Explain the harm reduction model and its relevance in assessing the effectiveness of treatment.
3. Describe how the 3 FDA-approved medications – methadone, buprenorphine, and naltrexone – work physiologically and practically from the perspective of the patient and the provider recommending these medications.
4. Discuss the role of naloxone and its universal role for all patients with OUD.
5. Explore the ways in which HIV medications are used as an adjunctive form of MAT.
6. Provide factual responses to common myths to help reduce the stigma associated with OUD and the medications used in its treatment
7. Empower learners to advocate for OUD medication with confidence and competence.
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 2 credit hours.
Chief Medical Officer
Dr. Ginter has nearly two decades of experience working in the addiction treatment field, is Board Certified in Addiction Medicine, and is a prominent voice in medication-assisted treatment (MAT). MAT, the use of FDA-approved medications in combination with counseling and behavioral therapies, is widely considered to be an effective tool in battling addiction to opioids and other drugs.
Dr. Ginter graduated from Yale University and earned her doctorate at the University of Maryland School of Medicine. She has lectured extensively on MAT and opioid dependence. Dr. Ginter started her career as a family doctor for underserved populations and eventually found a passion for helping pregnant women struggling with addiction. Most recently, she was the Regional Medical Director and Chief Medical Officer for an outpatient addiction treatment provider with 16 sites in Massachusetts, Maine, New Hampshire and Connecticut.